{"id":58293,"date":"2023-10-25T07:03:07","date_gmt":"2023-10-25T05:03:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/"},"modified":"2023-10-25T07:03:07","modified_gmt":"2023-10-25T05:03:07","slug":"lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/","title":{"rendered":"Lubrizol\u2019s Apisolex\u2122 Polymer Wins Finished Formulation Award at CPhI Barcelona"},"content":{"rendered":"
\n

\nSolubility-enhancing Excipient for Injectable Drug Formulations Wins Prestigious CPhI Barcelona Award<\/i><\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

CLEVELAND–(BUSINESS WIRE)–Lubrizol Life Science Health, a leading pharmaceutical company, has won the Finished Formulation Award at CPhI Barcelona for its innovative technology \u2013 Apisolex\u2122<\/a> Polymer solubilizing excipient. With over 180 entries covering 12 innovation categories featuring many of pharma\u2019s biggest names, Apisolex Polymer was again recognized as a breakthrough innovation adding to the prestigious award recognized by The Medicine Maker<\/a> earlier this year. The winners were announced at a networking reception held at CPhI Barcelona with over 500 guests in attendance.<\/p>\n

\nApisolex\u2122 Polymer is the first solubility-enhancing excipient to be launched specifically for parenteral use in over 20 years. Comprised of building blocks naturally occurring in the body, Apisolex\u2122 is a poly(amino acid)–based excipient that provides drug formulators with the necessary tools and methods to enhance the solubility of hydrophobic APIs by up to 50,000-fold.<\/p>\n

\nApproximately 60% of new chemical entities (NCEs) under development, and more than 40% of Active Pharmaceutical Ingredients (APIs) in reformulation are poorly water-soluble with each requiring tailored solutions. With several solubilizing excipients on the market, it is impossible to find a one-size-fits-all solution. Filling a crucial gap in the market, Apisolex\u2122 Polymer enables novel brick-dust and grease ball APIs to be formulated, as well as providing existing APIs with the option to be repurposed or reformulated via the FDA\u2019s 505(b)(2) regulatory pathway.<\/p>\n

\n\u201cBy drawing on our 40+ year legacy, Lubrizol Life Science Health has developed a non-immunogenic, biocompatible, and biodegradable alternative to PEG-based excipients. Apisolex\u2122 Polymer offers oncology, CNS, and high-value orphan drug formulators the tools necessary to unlock the potential of previously hard-to-formulate APIs, providing patients with access to life-changing therapeutics that otherwise may not have made it to market.\u201d – Gaurab Sengupta, Senior Global Business Director, Pharmaceuticals & Nutraceuticals, Lubrizol Life Science Health.<\/p>\n

\nRequest a sample or speak with a solubility enhancement expert today<\/a>.<\/p>\n

\nAbout Lubrizol<\/b><\/p>\n

\nThe Lubrizol Corporation, a Berkshire Hathaway company, is a specialty chemical company whose science delivers sustainable solutions to advance mobility, improve wellbeing and enhance modern life. Founded in 1928, Lubrizol owns and operates more than 100 manufacturing facilities, sales and technical offices around the world and has more than 8,000 employees. For more information, visit www.Lubrizol.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nGabe Ellis
\n
Global Marketing Communications Manager \u2013 Pharma
\n
Gabe.ellis@lubrizol.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Solubility-enhancing Excipient for Injectable Drug Formulations Wins Prestigious CPhI Barcelona Award CLEVELAND–(BUSINESS WIRE)–Lubrizol Life Science Health, a leading pharmaceutical company, has won the Finished Formulation Award at CPhI Barcelona for its innovative technology \u2013 Apisolex\u2122 Polymer solubilizing excipient. With over 180 entries covering 12 innovation categories featuring many of pharma\u2019s biggest names, Apisolex Polymer was … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58293","6":"format-standard","7":"category-industry"},"yoast_head":"\nLubrizol\u2019s Apisolex\u2122 Polymer Wins Finished Formulation Award at CPhI Barcelona - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lubrizol\u2019s Apisolex\u2122 Polymer Wins Finished Formulation Award at CPhI Barcelona - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Solubility-enhancing Excipient for Injectable Drug Formulations Wins Prestigious CPhI Barcelona Award CLEVELAND–(BUSINESS WIRE)–Lubrizol Life Science Health, a leading pharmaceutical company, has won the Finished Formulation Award at CPhI Barcelona for its innovative technology \u2013 Apisolex\u2122 Polymer solubilizing excipient. With over 180 entries covering 12 innovation categories featuring many of pharma\u2019s biggest names, Apisolex Polymer was ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-25T05:03:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231024985629\/en\/1924332\/21\/MicrosoftTeams-image-64.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Lubrizol\u2019s Apisolex\u2122 Polymer Wins Finished Formulation Award at CPhI Barcelona\",\"datePublished\":\"2023-10-25T05:03:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\\\/\"},\"wordCount\":390,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231024985629\\\/en\\\/1924332\\\/21\\\/MicrosoftTeams-image-64.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\\\/\",\"name\":\"Lubrizol\u2019s Apisolex\u2122 Polymer Wins Finished Formulation Award at CPhI Barcelona - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231024985629\\\/en\\\/1924332\\\/21\\\/MicrosoftTeams-image-64.jpg\",\"datePublished\":\"2023-10-25T05:03:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231024985629\\\/en\\\/1924332\\\/21\\\/MicrosoftTeams-image-64.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231024985629\\\/en\\\/1924332\\\/21\\\/MicrosoftTeams-image-64.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lubrizol\u2019s Apisolex\u2122 Polymer Wins Finished Formulation Award at CPhI Barcelona\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lubrizol\u2019s Apisolex\u2122 Polymer Wins Finished Formulation Award at CPhI Barcelona - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/","og_locale":"en_US","og_type":"article","og_title":"Lubrizol\u2019s Apisolex\u2122 Polymer Wins Finished Formulation Award at CPhI Barcelona - Pharma Trend","og_description":"Solubility-enhancing Excipient for Injectable Drug Formulations Wins Prestigious CPhI Barcelona Award CLEVELAND–(BUSINESS WIRE)–Lubrizol Life Science Health, a leading pharmaceutical company, has won the Finished Formulation Award at CPhI Barcelona for its innovative technology \u2013 Apisolex\u2122 Polymer solubilizing excipient. With over 180 entries covering 12 innovation categories featuring many of pharma\u2019s biggest names, Apisolex Polymer was ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/","og_site_name":"Pharma Trend","article_published_time":"2023-10-25T05:03:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231024985629\/en\/1924332\/21\/MicrosoftTeams-image-64.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Lubrizol\u2019s Apisolex\u2122 Polymer Wins Finished Formulation Award at CPhI Barcelona","datePublished":"2023-10-25T05:03:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/"},"wordCount":390,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231024985629\/en\/1924332\/21\/MicrosoftTeams-image-64.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/","url":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/","name":"Lubrizol\u2019s Apisolex\u2122 Polymer Wins Finished Formulation Award at CPhI Barcelona - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231024985629\/en\/1924332\/21\/MicrosoftTeams-image-64.jpg","datePublished":"2023-10-25T05:03:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231024985629\/en\/1924332\/21\/MicrosoftTeams-image-64.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231024985629\/en\/1924332\/21\/MicrosoftTeams-image-64.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/lubrizols-apisolex-polymer-wins-finished-formulation-award-at-cphi-barcelona\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Lubrizol\u2019s Apisolex\u2122 Polymer Wins Finished Formulation Award at CPhI Barcelona"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58293"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58293\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}